1887
Outbreaks Open Access
Like 0

Abstract

In September 2023, a measles outbreak occurred in a middle school (Rhône valley, France), with the index case returning from Asia. Investigations involved case validation, virological analyses, contact tracing and checking vaccination records to determine measles vaccination coverage (VC) and attack rates (AR). Among 643 students, 49 measles cases occurred between 6 September and 18 October 2023 (AR = 7.6%). Two-dose vaccination coverage was 93.5% (601/643). Virological analyses confirmed the measles strains’ clonality (genotype D8) and the imported origin. Concordance between health record vaccination status and immunological profile was established for 27 cases. In a sub-cohort of children (all cases and 309 non-cases), AR was 100% in unvaccinated children, and 43.7%, 16.5% and 3.2% among two-dose vaccinated children with the first dose administered at 6–8, 9–11 and ≥ 12 months, respectively. After multivariate binomial regression, vaccine effectiveness (VE) was 96.4% (95% confidence interval (CI): 91.4–98.5) after two-dose vaccination with the first dose at ≥ 12 months, confirming long-term effectiveness of measles-mumps-rubella vaccines. When the first dose was given at 9–11 and 6–8 months, respectively, VE was 83.3% (95% CI: 74.3–89.2) and 60.7% (95% CI: 10.6–82.7). This measles epidemic mainly affected unvaccinated or two-dose vaccinated children with first dose administered before age 12 months.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.46.2500130
2025-11-20
2025-12-08
/content/10.2807/1560-7917.ES.2025.30.46.2500130
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/46/eurosurv-30-46-4.html?itemId=/content/10.2807/1560-7917.ES.2025.30.46.2500130&mimeType=html&fmt=ahah

References

  1. Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017;17(12):e420-8.  https://doi.org/10.1016/S1473-3099(17)30307-9  PMID: 28757186 
  2. Hübschen JM, Gouandjika-Vasilache I, Dina J. Measles. Lancet. 2022;399(10325):678-90.  https://doi.org/10.1016/S0140-6736(21)02004-3  PMID: 35093206 
  3. Minta AA, Ferrari M, Antoni S, Lambert B, Sayi TS, Hsu CH, et al. Progress toward measles elimination - worldwide, 2000-2023. MMWR Morb Mortal Wkly Rep. 2024;73(45):1036-42.  https://doi.org/10.15585/mmwr.mm7345a4  PMID: 39541251 
  4. World Health Organization (WHO). Measles. Geneva: WHO; 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/measles
  5. World Health Organization (WHO). Rapid measles outbreak response critical to protect millions of vulnerable children. Geneva: WHO; 2024. Available from: https://www.who.int/europe/news/item/22-02-2024-rapid-measles-outbreak-response-critical-to-protect-millions-of-vulnerable-children
  6. Antona D, Lévy-Bruhl D, Baudon C, Freymuth F, Lamy M, Maine C, et al. Measles elimination efforts and 2008-2011 outbreak, France. Emerg Infect Dis. 2013;19(3):357-64.  https://doi.org/10.3201/eid1903.121360  PMID: 23618523 
  7. Huoi C, Casalegno JS, Bénet T, Neuraz A, Billaud G, Eibach D, et al. A report on the large measles outbreak in Lyon, France, 2010 to 2011. Euro Surveill. 2012;17(36):20264.  https://doi.org/10.2807/ese.17.36.20264-en  PMID: 22971330 
  8. Jaafar R, Zandotti C, Grimaldier C, Etoundi M, Kadri I, Boschi C, et al. Epidemiological and genetic characterization of measles virus circulating strains at Marseille, France during 2017-2019 measles outbreak. J Infect. 2021;83(3):361-70.  https://doi.org/10.1016/j.jinf.2021.07.011  PMID: 34310945 
  9. Santé publique France. Rougeole en France. Bilan annuel 2023. [Measles in France. Annual report 2023]. Saint-Maurice cedex: Santé publique France; 2024. French. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/rougeole/documents/bulletin-national/rougeole-en-france.-bilan-annuel-2023
  10. Santé publique France. Vaccination en Auvergne-Rhône-Alpes. Bilan de la couverture vaccinale en 2023. [Vaccination in Auvergne-Rhône-Alpes. Vaccination coverage report in 2023]. Saint-Maurice cedex: Santé publique France; 2024. French. Available from: https://www.santepubliquefrance.fr/regions/auvergne-rhone-alpes/documents/bulletin-regional/2024/vaccination-en-auvergne-rhone-alpes.-bilan-de-la-couverture-vaccinale-en-2023
  11. Santé publique France. Rougeole en France. Bilan annuel 2024. [Measles in France. Annual report 2024]. Saint-Maurice cedex: Santé publique France; 2025 [Accessed: 13 Jun 2025]. French. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-a-prevention-vaccinale/rougeole/documents/bulletin-national/rougeole-en-france.-bilan-annuel-2024
  12. World Health Organization Regional Office from Europe (WHO/Europe). 13th meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC). Copenhagen: WHO/Europe; 2025. Available from: https://www.who.int/europe/news-room/events/item/2024/09/10/default-calendar/13th-meeting-of-the-european-regional-verification-commission-for-measles-and-rubella-elimination-(rvc)
  13. Antona D, Lévy-Bruhl D, Baudon C, Freymuth F, Lamy M, Maine C, et al. Measles elimination efforts and 2008-2011 outbreak, France. Emerg Infect Dis. 2013;19(3):357-64.  https://doi.org/10.3201/eid1903.121360  PMID: 23618523 
  14. Santé publique France. Liste des maladies à déclaration obligatoire. [List of notifiable diseases]. Saint-Maurice cedex: Santé publique France; 2023. French. Available from: https://www.santepubliquefrance.fr/maladies-a-declaration-obligatoire/liste-des-maladies-a-declaration-obligatoire
  15. Ministère des solidarités et de la santé. Instruction n° DGS/SP/SP1/2018/205 du 28 septembre 2018 relative à la conduite à tenir autour d’un ou plusieurs cas de rougeole. [Instruction no. DGS/SP/SP1/2018/205 of 28 September 2018 relating to the conduct to be adopted in the event of one or more cases of measles]. Paris: Légifrance; 2018. French. Available from: https://www.legifrance.gouv.fr/circulaire/id/44038
  16. Althaus CL, Salathé M. Measles vaccination coverage and cases among vaccinated persons. Emerg Infect Dis. 2015;21(8):1480-1.  https://doi.org/10.3201/eid2108.150284  PMID: 26196331 
  17. Pannuti CS, Morello RJ, Moraes JC, Curti SP, Afonso AMS, Camargo MCC, et al. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic. Clin Diagn Lab Immunol. 2004;11(1):119-22. PMID: 14715557 
  18. Iwamoto M, Hickman CJ, Colley H, Arciuolo RJ, Mahle CE, Deocharan B, et al. Measles infection in persons with secondary vaccine failure, New York City, 2018-19. Vaccine. 2021;39(38):5346-50.  https://doi.org/10.1016/j.vaccine.2021.07.078  PMID: 34393016 
  19. Domínguez A, Torner N, Barrabeig I, Rovira A, Rius C, Cayla J, et al. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule. Clin Infect Dis. 2008;47(9):1143-9.  https://doi.org/10.1086/592258  PMID: 18823269 
  20. Augusto GF, Silva A, Pereira N, Fernandes T, Leça A, Valente P, et al. Report of simultaneous measles outbreaks in two different health regions in Portugal, February to May 2017: lessons learnt and upcoming challenges. Euro Surveill. 2019;24(3):1800026.  https://doi.org/10.2807/1560-7917.ES.2019.24.3.1800026  PMID: 30670145 
  21. Pampaka D, López-Perea N, Fernández-García A, Huertas-Zarco I, Castellanos-Martínez M, Villatoro-Bongiorno K, et al. An interregional measles outbreak in Spain with nosocomial transmission, November 2017 to July 2018. Euro Surveill. 2023;28(17):2200634.  https://doi.org/10.2807/1560-7917.ES.2023.28.17.2200634  PMID: 37103785 
  22. van den Hof S, Meffre CM, Conyn-van Spaendonck MA, Woonink F, de Melker HE, van Binnendijk RS. Measles outbreak in a community with very low vaccine coverage, the Netherlands. Emerg Infect Dis. 2001;7(3) Suppl;593-7.  https://doi.org/10.3201/eid0707.010743  PMID: 11485681 
  23. Georgakopoulou T, Horefti E, Vernardaki A, Pogka V, Gkolfinopoulou K, Triantafyllou E, et al. Ongoing measles outbreak in Greece related to the recent European-wide epidemic. Epidemiol Infect. 2018;146(13):1692-8.  https://doi.org/10.1017/S0950268818002170  PMID: 30086813 
  24. Bernadou A, Astrugue C, Méchain M, Le Galliard V, Verdun-Esquer C, Dupuy F, et al. Measles outbreak linked to insufficient vaccination coverage in Nouvelle-Aquitaine Region, France, October 2017 to July 2018. Euro Surveill. 2018;23(30):1800373.  https://doi.org/10.2807/1560-7917.ES.2018.23.30.1800373  PMID: 30064543 
  25. Franconeri L, Antona D, Cauchemez S, Lévy-Bruhl D, Paireau J. Two-dose measles vaccine effectiveness remains high over time: A French observational study, 2017-2019. Vaccine. 2023;41(39):5797-804.  https://doi.org/10.1016/j.vaccine.2023.08.018  PMID: 37586955 
  26. Hughes SL, Bolotin S, Khan S, Li Y, Johnson C, Friedman L, et al. The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic review. Vaccine. 2020;38(3):460-9.  https://doi.org/10.1016/j.vaccine.2019.10.090  PMID: 31732326 
  27. Carazo S, Billard MN, Boutin A, De Serres G. Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):251.  https://doi.org/10.1186/s12879-020-4870-x  PMID: 32223757 
  28. Brinkman ID, de Wit J, Smits GP, Ten Hulscher HI, Jongerius MC, Abreu TC, et al. Early measles vaccination during an outbreak in the Netherlands: short-term and long-term decreases in antibody responses among children vaccinated before 12 months of age. J Infect Dis. 2019;220(4):594-602.  https://doi.org/10.1093/infdis/jiz159  PMID: 30972418 
  29. World Health Organization. Measles vaccines: WHO position paper, April 2017 - Recommendations. Vaccine. 2019;37(2):219-22. . https://doi.org/10.1016/j.vaccine.2017.07.066  PMID: 28760612 
  30. Centers for Disease Control and Prevention (CDC). Measles cases and outbreaks. Atlanta: CDC; [Accessed: 21 Oct 2025]. Available from: https://www.cdc.gov/measles/data-research/index.html
  31. Leung J, Munir NA, Mathis AD, Filardo TD, Rota PA, Sugerman DE, et al. The effects of vaccination status and age on clinical characteristics and severity of measles cases in the United States in the postelimination era, 2001-2022. Clin Infect Dis. 2025;80(3):663-72.  https://doi.org/10.1093/cid/ciae470  PMID: 39271123 
/content/10.2807/1560-7917.ES.2025.30.46.2500130
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error